Publication: Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients.
dc.contributor.author | Trujillo-Rodriguez, Maria | |
dc.contributor.author | Muñoz-Muela, Esperanza | |
dc.contributor.author | Serna-Gallego, Ana | |
dc.contributor.author | Praena-Fernandez, Juan Manuel | |
dc.contributor.author | Perez-Gomez, Alberto | |
dc.contributor.author | Gasca-Capote, Carmen | |
dc.contributor.author | Vitalle, Joana | |
dc.contributor.author | Peraire, Joaquim | |
dc.contributor.author | Palacios-Baena, Zaira R | |
dc.contributor.author | Cabrera, Jorge Julio | |
dc.contributor.author | Ruiz-Mateos, Ezequiel | |
dc.contributor.author | Poveda, Eva | |
dc.contributor.author | Lopez-Cortes, Luis Eduardo | |
dc.contributor.author | Rull, Anna | |
dc.contributor.author | Gutierrez-Valencia, Alicia | |
dc.contributor.author | Lopez-Cortes, Luis Fernando | |
dc.contributor.funder | Consejeria de Salud y Familia | |
dc.contributor.funder | Consejeria de Transformacion Economica, Industria, Conocimiento y Universidades | |
dc.contributor.funder | Instituto de Salud Carlos III Spanish Government | |
dc.contributor.funder | Centro de Investigacion Biomedica en Red de Enfermedades Infecciosas-ISCIII Madrid, Spain | |
dc.date.accessioned | 2023-05-03T13:36:46Z | |
dc.date.available | 2023-05-03T13:36:46Z | |
dc.date.issued | 2022-07-14 | |
dc.description.abstract | The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation. Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening. 333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%). Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities. | |
dc.description.version | Si | |
dc.identifier.citation | Trujillo-Rodriguez M, Muñoz-Muela E, Serna-Gallego A, Praena-Fernández JM, Pérez-Gómez A, Gasca-Capote C, et al. Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. PLoS One. 2022 Jul 14;17(7):1-15. | |
dc.identifier.doi | 10.1371/journal.pone.0269875 | |
dc.identifier.essn | 1932-6203 | |
dc.identifier.pmc | PMC9282584 | |
dc.identifier.pmid | 35834501 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282584/pdf | |
dc.identifier.unpaywallURL | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0269875&type=printable | |
dc.identifier.uri | http://hdl.handle.net/10668/20431 | |
dc.issue.number | 7 | |
dc.journal.title | PloS one | |
dc.journal.titleabbreviation | PLoS One | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen Macarena | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.page.number | 15 | |
dc.provenance | Realizada la curación de contenido 03/04/2025 | |
dc.publisher | Public Library of Science | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.relation.projectID | COVID-00052020 | |
dc.relation.projectID | RH-0037-2020 | |
dc.relation.projectID | PY20/01276 | |
dc.relation.projectID | CP19/00159 | |
dc.relation.projectID | CP19/00146 | |
dc.relation.projectID | FI19/00304 | |
dc.relation.projectID | FI19/00083 | |
dc.relation.projectID | COV20/00698 | |
dc.relation.publisherversion | https://dx.plos.org/10.1371/journal.pone.0269875 | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | COVID-19 | |
dc.subject | Humans | |
dc.subject | Patient Discharge | |
dc.subject.decs | Pacientes | |
dc.subject.decs | Laboratorios | |
dc.subject.decs | Citocinas | |
dc.subject.decs | Hospitales | |
dc.subject.decs | Corticoesteroides | |
dc.subject.decs | Saturación de oxígeno | |
dc.subject.decs | Pandemias | |
dc.subject.decs | Neutrófilos | |
dc.subject.decs | Interferones | |
dc.subject.decs | Interleucina-1beta | |
dc.subject.decs | Linfocitos | |
dc.subject.mesh | Biomarkers | |
dc.subject.mesh | Cytokines | |
dc.subject.mesh | Male | |
dc.subject.mesh | SARS-CoV-2 | |
dc.title | Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 17 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 3 of 3
No Thumbnail Available
- Name:
- Trujillo-Rodriguez_ClinicalLaboratory_Correción.pdf
- Size:
- 223.74 KB
- Format:
- Adobe Portable Document Format
No Thumbnail Available
- Name:
- Trujillo-Rodriguez_ClinicalLaboratory_MaterialSuplementario.zip
- Size:
- 1.37 MB
- Format: